Extracorporeal Shock Wave Therapy Not Recommended for Peyronie's Disease
German researchers have concluded that extracorporeal shock wave therapy (ESWT) cannot be recommended to treat Peyronie's disease.
Their report, published online in July in the Journal of Sexual Medicine, showed that while ESWT could help some men with pain, it did not improve deviation, plaque size, or sexual function.
One hundred two men with Peyronie's disease participated in the study. Half were randomly assigned to receive 6 weeks of ESWT treatment. The other half formed a placebo group.
The researchers wrote that ESWT might be helpful for men with pain that can't be managed in other ways. However, since pain is not considered a major symptom of Peyronie's disease, using ESWT for this purpose would not always justify the cost and number of treatments needed. Pain usually resolves on its own and many men benefit from pain medication.
Penile deviation, usually the biggest concern for men with Peyronie's disease, was generally not corrected with ESWT. In fact, 40% of the men receiving ESWT saw their deviation get worse.
Click here to learn more about this study.
Clinical Research Forum Launches on ISSM.info
Have you seen the new Clinical Research category in the ISSM Member Forums?
This new forum gives members an opportunity to discuss preparing, organizing, and interpreting clinical research. It joins several other popular forums, such as those covering sexual health for men and for women.
Members must subscribe to the new forum. To do so, click here for forum access. Once you are signed in, you can manage your subscriptions by clicking on the appropriate links.
Not an ISSM member? The Member Forums are just one of many benefits of an ISSM membership. Click here to learn more!
|
